Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer

Medicine and Dentistry

• Colorectal Cancer 100%
• Cell Cycle Progression 100%
• Proto Oncogene 100%
• Cyclin D1 75%
• Malignant Neoplasm 50%
• Cancer Growth 50%
• Cell Cycle 50%
• Colorectal Cancer Cell Line 50%
• Biological Marker 25%
• Metastatic Carcinoma 25%
• Cell Proliferation 25%
• Programmed Cell Death 25%
• Protein Tyrosine Kinase 25%
• Binding Affinity 25%
• Cell Invasion 25%
• Cell Motility 25%
• Distant Metastasis 25%
• Oncogene 25%
• Early Diagnosis 25%
• Antineoplastic Activity 25%
• Targeted Therapy 25%
• Docking (Molecular) 25%
• In Silico 25%
• Regulator Protein 25%
• Cell Oncogene 25%
• Drug Resistance 25%
• Cytotoxicity 25%
• Transcription Factors 25%
• Pathogenicity 25%

Biochemistry, Genetics and Molecular Biology

• Small Molecule 100%
• Cell Cycle Progression 100%
• Proto Oncogene 100%
• Cyclin D1 100%
• Cancer Cell 66%
• Cell Cycle 66%
• Cell Proliferation 33%
• Binding Affinity 33%
• Computer Model 33%
• Antineoplastic Activity 33%
• Cell Invasion 33%
• Cell Motility 33%
• Tyrosine Kinase 33%
• Oncogene 33%
• Docking (Molecular) 33%
• Cell Oncogene 33%
• Receptor Tyrosine Kinase 33%
• Drug Resistance 33%
• Cytotoxicity 33%
• Transcription Factors 33%

Immunology and Microbiology

• Cell Cycle Progression 100%
• Cyclin D1 100%
• Proto Oncogene 100%
• Colorectal Cancer Cell Line 66%
• Cell Cycle 66%
• Cell Proliferation 33%
• Computer Model 33%
• Binding Affinity 33%
• Cytotoxicity 33%
• Antineoplastic Activity 33%
• Oncogene 33%
• Drug Resistance 33%
• Cell Motility 33%
• Cell Oncogene 33%
• Cell Invasion 33%
• Molecular Docking 33%
• Transcription Factors 33%
• Pathogenicity 33%